Hyperion Defi (HYPD) Interest Expenses (2016 - 2026)
Hyperion Defi (HYPD) posted quarterly Interest Expenses of $225869.0 for Q1 2026, down 61.16% year-over-year from $581499.0 in Q1 2025, and down 82.11% quarter-over-quarter from $1.3 million in Q4 2025.
Hyperion Defi (HYPD) Interest Expenses (2016 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Interest Expenses for 11 consecutive years, with $225869.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses fell 61.16% year-over-year to $225869.0; the TTM figure through Mar 2026 stood at $2.2 million (down 8.31% YoY), while the FY2025 annual figure was $49.8 million, up 1905.71% from the prior year.
- Interest Expenses fell to $225869.0 in Q1 2026 per HYPD's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $2.6 million in Q2 2023 and bottomed at -$286301.0 in Q4 2022.
- Historically, Interest Expenses has averaged $783930.6 across 5 years, with a median of $528410.0 in 2025.
- On a YoY basis, Interest Expenses climbed as much as 2721.23% in 2022 and fell as far as 254.47% in 2022.
- Hyperion Defi's Interest Expenses stood at -$286301.0 in 2022, then jumped by 333.3% to $667929.0 in 2023, then fell by 23.03% to $514095.0 in 2024, then surged by 145.57% to $1.3 million in 2025, then sank by 82.11% to $225869.0 in 2026.
- Business Quant data shows HYPD's Interest Expenses at $225869.0 in Q1 2026, $1.3 million in Q4 2025, and $223080.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 93.62 Mn |
| 10 | Hyperion Defi | 48.05 Mn | 38.41 Mn | 357,693.00 | 233,760.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 233,760.00 |
| Jun 30, 2026 | 233,760.00 |
| Mar 31, 2026 | 225,869.00 |
| Mar 31, 2026 | 225,869.00 |
| Dec 31, 2025 | 1.26 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 223,080.00 |
| Sep 30, 2025 | 223,080.00 |
| Jun 30, 2025 | 528,410.00 |
| Jun 30, 2025 | 528,410.00 |
| Mar 31, 2025 | 581,499.00 |
| Mar 31, 2025 | 581,499.00 |
| Dec 31, 2024 | 514,095.00 |
| Dec 31, 2024 | 514,095.00 |
| Sep 30, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Mar 31, 2024 | 1.99 Mn |